The Global Artificial Intelligence Diagnostics Market Growth Accelerated by Advancements in AI and Deep Learning Algorithms
Artificial Intelligence
Diagnostics refers to the integration of AI and machine learning technologies
to improve diagnostic accuracy and assist physicians in making clinical
decisions. AI can analyse medical images, pathology slides, and genomic data to
identify biomarkers, detect anomalies, make precise measurements, count cells
and objects, and segment tissues. This helps radiologists and pathologists
enhance their workflow and diagnostic capabilities.
The global Artificial
Intelligence Diagnostics Market is estimated to be valued at US$ 1502.9 Mn in 2023 and is expected
to exhibit a CAGR of 9% over the
forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market key trends:
One of the key trends driving the growth of the Artificial Intelligence
Diagnostics Market is the advancements in AI and deep learning algorithms. Deep
learning algorithms are able to extract features from large and complex medical
datasets that are difficult for humans to analyze. Advancements such as
convolutional neural networks and transfer learning allow AI models to learn
patterns from vast amounts of imaging and genomic data. This enhances their
ability to recognize anomalies, make fine-grained diagnoses, and detect
diseases at an early stage. As datasets continue to grow exponentially,
advancement in deep learning will facilitate more accurate diagnostic models
and drive the adoption of AI diagnostics.
Segment Analysis
The global artificial intelligence diagnostics market is dominated by the
software segment. The software tools play a pivotal role in diagnostic
applications as they help analyze medical images, signals and patient records.
With more and more healthcare facilities adopting AI technologies, the demand
for diagnostic software is growing significantly. Furthermore, as AI algorithms
require huge amounts of data, software companies are focusing on developing
sophisticated tools that can efficiently handle high volumes of healthcare
data.
Key Takeaways
The Global
Artificial Intelligence Diagnostics Market Size is expected to witness
high growth over the forecast period of 2023 to 2030. The global Artificial
Intelligence Diagnostics Market is estimated to be valued at US$ 1502.9 Mn in 2023 and is expected
to exhibit a CAGR of 9% over the
forecast period 2023 to 2030.
The North American region currently dominates the global AI diagnostics market
and is expected to maintain its leading position during the forecast period as
well. High prevalence of chronic diseases, well-developed healthcare
infrastructure, rapid adoption of cutting-edge technologies are some key
factors driving the growth of artificial intelligence diagnostics market in the
region.
Key players
Key players operating in the artificial intelligence diagnostics market are GE
Healthcare, Siemens Healthineers, Philips Healthcare , Cardinal Health ,
Lantheus Medical Imaging, Bayer AG, Bracco Imaging, Eczacıbaşı-Monrol
Nuclear Products , Nordion, Advanced Accelerator Applications, NTP
Radioisotopes, Curium Pharma, Jubilant Life Sciences Ltd , IRE €“ IRE ELiT €“ Instituto
de Pesquisas Energéticas e Nucleares, Australian Nuclear Science and
Technology Organisation (ANSTO), Eckert & Ziegler Radiopharma GmbH,
Isotopia Molecular Imaging Ltd. , Institute of Atomic Energy of Bangladesh ,
Rosatom State Atomic Energy Corporation, Board of Radiation and Isotope
Technology (BRIT).
For More Insights, Read: https://www.newswirestats.com/artificial-intelligence-diagnostics-market-size-share-and-growth-forecast-2023-2030/
Comments
Post a Comment